362 Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivo | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Ovarian cancer

362 Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivo

Free

Online download statistics by month:

Online download statistics by month: October 2021 to March 2023

	Abstract	Full	Pdf
Oct 2021	44	0	9
Nov 2021	42	0	12
Dec 2021	8	0	0
Jan 2022	39	0	6
Feb 2022	12	0	1
Mar 2022	14	0	5
Apr 2022	5	0	4
May 2022	28	0	14
Jun 2022	22	0	4
Jul 2022	41	0	5
Aug 2022	21	0	3
Sep 2022	18	0	5
Oct 2022	33	0	9
Nov 2022	19	0	3
Dec 2022	18	0	4
Jan 2023	25	0	7
Feb 2023	14	0	2
Mar 2023	6	0	0
Total	409	0	93